Treatment with an anti–tumor necrosis factor agent is effective for induction and maintenance of remission in Crohn disease and is generally considered to be safe during pregnancy (FDA pregnancy category B).
If you want to change selection, open document below and click on "Move attachment"
pdf
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p2618
Summary
| status | not read | | reprioritisations | |
|---|
| last reprioritisation on | | | suggested re-reading day | |
|---|
| started reading on | | | finished reading on | |
|---|
Details